Live Breaking News & Updates on Gabriel science

Stay informed with the latest breaking news from Gabriel science on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Gabriel science and stay connected to the pulse of your community

Sonoma Pharmaceuticals Inc. (SNOA) is set for a tempting yields with an average volume of 1.98M

Sonoma Pharmaceuticals Inc. (SNOA) is set for a tempting yields with an average volume of 1.98M
investchronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investchronicle.com Daily Mail and Mail on Sunday newspapers.

Switzerland , Warren-buffett , Sonoma-pharmaceuticals-inc , Gabriel-science , Sonoma-pharmaceuticals-announces-expanded-dental-care-line , Systems-solutions , Nasdaq , Sonoma-pharmaceuticals , New-product , Professional-care , Consumer-care , Genix-oral-hygiene-rinse

Sonoma Pharmaceuticals Announces Expanded Dental Care Line with a New Product for Professional Care in the U.S. and a New Product for Professional and Consumer Care in Switzerland

Sonoma Pharmaceuticals Announces Expanded Dental Care Line with a New Product for Professional Care in the U.S. and a New Product for Professional and Consumer Care in Switzerland
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Switzerland , Sonoma-pharmaceuticals-inc , Gabriel-science , Systems-solutions , Sonoma-pharmaceuticals , Genix-oral-hygiene-rinse , Medical-systems-solutions , Oral-care , சுவிட்சர்லாந்து , சோணோமா-மருந்துகள்-இன்க் , கேப்ரியல்-அறிவியல்

Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces Expanded Dental Care Line with a New Product for Professional Care in the U.S. and a New Product for Professional and Consumer Care in Switzerland

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications

Colorado , United-states , Niwot , Georgia , Netherlands , Switzerland , Roermond , Limburg , America , Mark-fontenot , Bruce-thornton , Edgar-sommer

Sonoma Pharmaceuticals Inc. (SNOA) is on the roll with an average volume of 107.77K in the recent 3 months

Sonoma Pharmaceuticals Inc. (SNOA) is on the roll with an average volume of 107.77K in the recent 3 months
investchronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investchronicle.com Daily Mail and Mail on Sunday newspapers.

Switzerland , Warren-buffett , Sonoma-pharmaceuticals-inc , Gabriel-science , Sonoma-pharmaceuticals-announces-expanded-dental-care-line , Systems-solutions , Nasdaq , Sonoma-pharmaceuticals , New-product , Professional-care , Consumer-care , Genix-oral-hygiene-rinse

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2021 Financial Results

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2021 Financial Results
|
0
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care,
eye, oral and nasal care and dermatological conditions today announced financial results for fiscal year 2021 and the fourth quarter ended March 31, 2021.
“For the past 18 months we have been restructuring the Company to cut losses while positioning it for growth,” said Amy Trombly, CEO. “Last year we consolidated all manufacturing at our factory in
Mexico (June), and ended our contract with Invekra that required us to sell product with low margin (October). This year, we entered into a partnership agreement with EMC Pharma, LLC for the sale

Germany , Georgia , United-states , New-zealand , Thailand , Hong-kong , Netherlands , Egypt , Roermond , Limburg , Portugal , France

Sonoma Pharmaceuticals Announces Partnership with Gabriel Science, LLC For Dental Markets

Sonoma Pharmaceuticals Announces Partnership with Gabriel Science, LLC For Dental Markets
Sonoma Pharmaceuticals Announces Partnership with Gabriel Science, LLC For Dental Markets
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, disinfectant use and dermatological conditions, today announced that it has entered into a non-exclusive distribution agreement with Gabriel Science, LLC for the sale of Microcyn Technology products into the dental market and has accepted its first order.
Endocyn, a Microcyn Technology product manufactured by Sonoma, is a biocompatible root canal irrigant that does not stain teeth or restorations. In a study conducted by the Departments of Endodontics and Cell Biology and Anatomy at Louisiana State University School of Dentistry published in the Journal of Endodontics, Regenerative Endodontics, Endocyn demonstrated less cellular toxicity compared to traditional endodontic irrigants such as sodium hypochlorite. The full study can be found here: https://www.sciencedirect.com/science/article/abs/pii/S0099239917310439

Colorado , United-states , Niwot , Louisiana , Georgia , Netherlands , Roermond , Limburg , America , Mark-fontenot , Amy-trombly , Exchange-commission

APPLIED DNA SCIENCES (APDN), (DARE) - Why Sonoma, Medicenna And Dare Bioscience Are Trading Higher Today

Share:
Sonoma Pharmaceuticals (NASDAQ: SNOA) shares are trading higher on Friday after the company announced a partnership with Gabriel Science for dental markets.
Sonoma is engaged in identifying, developing and commercializing differentiated therapies to patients living with chronic skin conditions.
Sonoma shares were trading up 13.22% at $8.64 on Friday. The stock has a 52-week high of $19.60 and a 52-week low of $3.55.
Medicenna Therapeutics (NASDAQ: MDNA) shares are trading higher after Oppenheimer initiated coverage on the stock with an Outperform rating and announced a $12 price target.
Medicenna Therapeutics Corp is a Canada based immuno-oncology company. Its principal business activity is the development and commercialization of Empowered Cytokines and Superkines for the treatment of cancer.

Canada , Medicenna-therapeutics-corp , Sonoma-pharmaceuticals , Dare-bioscience-inc , Hc-wainwright-co , Gabriel-science , Therapeutics-corp , Empowered-cytokines , Bioscience-inc , கனடா , சோணோமா-மருந்துகள்

Sonoma Pharmaceuticals Announces Partnership with Gabriel Science, LLC For Dental Markets

Posted on
8389
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, disinfectant use and dermatological conditions, today announced that it has entered into a non-exclusive distribution agreement with Gabriel Science, LLC for the sale of Microcyn® Technology products into the dental market and has accepted its first order.
Endocyn®, a Microcyn® Technology product manufactured by Sonoma, is a biocompatible root canal irrigant that does not stain teeth or restorations. In a study conducted by the Departments of Endodontics and Cell Biology and Anatomy at Louisiana State University School of Dentistry published in the Journal of Endodontics, Regenerative Endodontics, Endocyn demonstrated less cellular toxicity compared to traditional endodontic irrigants such as sodium hypochlorite. The full study can be found here: http://www.sciencedirect.com/science/article/abs/pii/S0099239917310439

Colorado , United-states , Niwot , Louisiana , Georgia , Netherlands , Roermond , Limburg , America , Mark-fontenot , Amy-trombly , Exchange-commission

10 Stocks Moving In Thursday's After-Hours Session

Share:
Gainers
Mereo BioPharma (NASDAQ: MREO) shares are trading higher after the company, and Ultragenyx, announced a license and collaboration agreement for setrusumab, a monoclonal antibody in clinical development for osteogenesis imperfecta.
Sonoma Pharmaceuticals (NASDAQ: SNOA) shares are trading higher after the company announced a partnership with Gabriel Science for dental markets.
Medicenna Therapeutics (NASDAQ: MDNA) shares are trading higher after Oppenheimer initiated coverage on the stock with an Outperform rating and set a $12 price target.
Losers
Applied DNA Sciences (NASDAQ: APDN) shares are trading lower after the company reported worse-than-expected Q4 EPS and sales results.
FedEx (NYSE: FDX) shares are trading lower after the company reported Q2 earnings results. The company did not provide 2021 guidance.

United-states , United-parcel-service , Fedex , Sonoma-pharmaceuticals , Gabriel-science , Parcel-service , States-steel , ஒன்றுபட்டது-மாநிலங்களில் , ஒன்றுபட்டது-பார்சல்-சேவை , ஃபெடெக்ஸ் , சோணோமா-மருந்துகள்